Allergy Therapeutics plc (LON:AGY – Get Free Report)’s share price traded down 11.6% during mid-day trading on Friday . The stock traded as low as GBX 5.20 ($0.07) and last traded at GBX 5.20 ($0.07). 687,506 shares changed hands during trading, a decline of 1% from the average session volume of 695,294 shares. The stock had previously closed at GBX 5.88 ($0.07).
Allergy Therapeutics Price Performance
The company’s 50-day simple moving average is GBX 5.05 and its 200-day simple moving average is GBX 4.84. The company has a debt-to-equity ratio of 37.22, a quick ratio of 1.48 and a current ratio of 1.40. The company has a market capitalization of £262.35 million, a PE ratio of -86.67, a P/E/G ratio of -30.70 and a beta of 1.40.
About Allergy Therapeutics
Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.
Featured Stories
- Five stocks we like better than Allergy Therapeutics
- How to Invest in Insurance Companies: A Guide
- Fast-Growing Companies That Are Still Undervalued
- Investing in Commodities: What Are They? How to Invest in Them
- Top Cybersecurity Stock Picks for 2025
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Archer or Joby: Which Aviation Company Might Rise Fastest?
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
